Traitement en cours

Veuillez attendre...

Paramétrages

Paramétrages

1. WO2005007117 - FORMULATION PHARMACEUTIQUE ET PROCEDE DE TRAITEMENT DE TROUBLES GASTRO-INTESTINAUX LIES A L'ACIDITE

Numéro de publication WO/2005/007117
Date de publication 27.01.2005
N° de la demande internationale PCT/US2004/023044
Date du dépôt international 16.07.2004
Demande présentée en vertu du Chapitre 2 13.06.2005
CIB
A61K 9/14 2006.01
ANÉCESSITÉS COURANTES DE LA VIE
61SCIENCES MÉDICALE OU VÉTÉRINAIRE; HYGIÈNE
KPRÉPARATIONS À USAGE MÉDICAL, DENTAIRE OU POUR LA TOILETTE
9Préparations médicinales caractérisées par un aspect particulier
14à l'état particulaire, p.ex. poudres
CPC
A61K 31/4439
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435having six-membered rings with one nitrogen as the only ring hetero atom
44Non condensed pyridines; Hydrogenated derivatives thereof
4427containing further heterocyclic ring systems
4439containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
A61K 47/02
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
02Inorganic compounds
A61K 47/36
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
A61K 9/0095
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
0087Galenical forms not covered by A61K9/02 - A61K9/7023
0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
A61K 9/10
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
10Dispersions; Emulsions
A61K 9/14
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
14Particulate form, e.g. powders, ; Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
Déposants
  • SANTARUS, INC. [US/US]; 10590 West Ocean Air Drive Suite 200 San Diego, CA 92130, US (AllExceptUS)
  • HALL, Warren [US/US]; US (UsOnly)
  • OLMSTEAD, Kay [KR/US]; US (UsOnly)
  • WESTON, Laura [US/US]; US (UsOnly)
Inventeurs
  • HALL, Warren; US
  • OLMSTEAD, Kay; US
  • WESTON, Laura; US
Mandataires
  • HADDACH, Aubrey; Wilson Sonsini Goodrich & Rosati 650 Page Mill Road Palo Alto, CA 94306-1050, US
Données relatives à la priorité
60/488,32418.07.2003US
Langue de publication anglais (EN)
Langue de dépôt anglais (EN)
États désignés
Titre
(EN) PHARMACEUTICAL FORMULATION AND METHOD FOR TREATING ACID-CAUSED GASTROINTESTINAL DISORDERS
(FR) FORMULATION PHARMACEUTIQUE ET PROCEDE DE TRAITEMENT DE TROUBLES GASTRO-INTESTINAUX LIES A L'ACIDITE
Abrégé
(EN)
Pharmaceutical formulations in the form of a powder for suspension comprising at least one proton pump inhibitor in micronized form; at least one antacid; and at least one suspending agents are provided herein. Also provided herein are methods for making and using pharmaceutical formulations comprising at least one proton pump inhibitor and at least one antacid.
(FR)
L'invention concerne des formulations pharmaceutiques sous forme de poudre pour une suspension, qui comprennent : au moins un inhibiteur de la pompe à protons sous forme micronisée ; au moins un antiacide ; et au moins un agent de suspension. L'invention concerne également des procédés de production et d'utilisation de formulations pharmaceutiques qui comprennent au moins un inhibiteur de la pompe à protons et au moins un antiacide.
Autres publications associées
Dernières données bibliographiques dont dispose le Bureau international